21. 249 Minimally invasive surgery improves overall survival for endometrial cancer. (13th November 2020) Authors: Carbajal-Mamani, S; Shoraka, M; Wang, Y; Lee, J; Dideban, B; Cardenas-Goicoechea, J Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. 26ODe-escalating axillary surgery according to neoadjuvant single or dual HER2 blockade in clinically node-positive, HER2-positive breast cancer. (24th November 2019) Authors: Cha, C; Kim, D; Lee, J; Park, S; Bae, S J; Kim, J Y; Ahn, S G; Park, H S; Park, S; Kim, S I; Cho, Y U; Jeong, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. 274 Colonization of Methicillin-Resistant Staphylococcus Aureus With High-Level Resistance To Mupirocin In Korean Children. (October 2012) Authors: Lee, JH; Kim, SJ; Lee, J; Lee, HS; Kim, SY; Sung, IK Journal: Archives of disease in childhood Issue: Volume 97(2012)Supplement 2 Page Start: A80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. 27PThe prognostic value of neutrophil to lymphocyte ratio (NLR) and 18F-FDG PET SUV in breast cancer patients underwent neoadjuvant chemotherapy. (24th November 2019) Authors: Bae, S J; Park, S; Cha, C; Lee, J; Kim, D; Ahn, S G; Jeong, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. 323 ENGOT-en9/LEAP-001: a phase 3 study of first-line pembrolizumab plus lenvatinib compared with chemotherapy in advanced or recurrent endometrial cancer. (13th November 2020) Authors: Randall, L; Marth, C; Vulsteke, C; Jesús Rubio, M; Makker, V; Braicu, I; McNeish, I; Madry, R; Ayhan, A; Hasegawa, K; Wu, X; Dutta, L; Xu, C; Keefe, S; Lee, J; Pignata, S Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. 325PAssociation between immune-related adverse events and efficacy of immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma. (24th November 2019) Authors: Wong, L; Ang, A; Ng, K; Tan, S H; Choo, S P; Tai, D; Lee, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. 367 Effect of waiting time from pathological diagnosis to definitive concurrent chemoradiation (CCRT) for cervical cancer on overall survival. (13th November 2020) Authors: Yeo, H; Noh, K; Lee, Y; Choi, CH; Kim, T; Lee, J; Kim, B; Bae, D; Cho, W; Park, W Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. 373PCell-free DNA (cfDNA) landscape in ERBB2 (HER2)-amplified Asian cancer patient population. (25th November 2018) Authors: Lee, J; Franovic, A; Rich, T A; Shiotsu, Y; Raymond, V M; Lanman, R B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. 374PAre we there yet? A critical reflection of Asian medical oncologists on NGS-guided precision treatment in Asia 2018. (25th November 2018) Authors: Lai, A; Seo Tho, W S; Poon, S L; Tan, K T; Tung, K; Lee, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. 378PCirculating cell-free DNA molecular profiling among east Asian patients reveals activating MET alterations are common in diverse advanced cancer types. (25th November 2018) Authors: Ikeda, S; Kumaki, Y; Rich, T A; Shiotsu, Y; Franovic, A; Raymond, V M; Kurzrock, R; Lanman, R B; Lee, J; Mok, T S K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗